News

SAN DIEGO–(BUSINESS WIRE)–Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced it will report fourth quarter and full year 2025 financial results on Thursday, February 19, 2026, after the close of the U.S. financial markets. The Company […]

SAN DIEGO, Feb. 12, 2026 (GLOBE NEWSWIRE) — Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi” or the “Company”), a biotechnology company pioneering the development of targeted genetic medicines, today announced that it will present data […]

MATAWAN, N.J. & LA JOLLA, Calif.–(BUSINESS WIRE)–Apimeds Pharmaceuticals US, Inc. and L?kahi Therapeutics, Inc. today announced that the U.S. Food and Drug Administration (FDA) Division of Anesthesiology, Addiction Medicine and Pain Medicine (DAAP) has confirmed […]

SAN DIEGO–(BUSINESS WIRE)– #Board–Curebound, a philanthropic organization that funds innovative cancer research, adds five prominent business leaders to Board Click here to view original post Click Here to Publish/Feature Your Company or Product News with […]

BOSTON–(BUSINESS WIRE)–Wilson Sonsini Goodrich & Rosati, the premier provider of legal services to technology, life sciences, and growth enterprises worldwide, today announced that nationally recognized corporate life sciences partner Karen Deschaine has relocated from the […]

A small startup based in San Diego and Shanghai believes it has figured out how to boost hemoglobin levels with a pill, potentially offering a cheaper and simpler alternative to expensive and onerous gene editing […]

SAN DIEGO–(BUSINESS WIRE)– #bioprocess–Nucleus Biologics launched the Krakatoa® K500, a pod-based, on-demand manufacturing system that produces 35–500L of media and buffers at point of use. Click here to view original post Click Here to Publish/Feature […]

SAN DIEGO–(BUSINESS WIRE)–Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its fourth quarter and full year 2025 financial and operating […]

Antibiotic resistance has steadily accelerated in recent years to become a global health crisis with estimates of more than 10 million worldwide deaths per year by 2050. Antibiotic-resistant bacteria are known to flourish in hospital […]

SAN DIEGO & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Iambic, a clinical-stage life science and technology company developing novel medicines using its AI-driven discovery and development platform, today announced a multi-year technology and discovery collaboration agreement with Takeda that […]

Takeda has signed another AI-focused deal, this time focusing on small molecules with the San Diego biotech Iambic. The two announced the multiyear deal Monday, working on undisclosed targets in the oncology, gastrointestinal and inflammation […]

Researchers have made rapid progress in recent years toward understanding the molecular underpinnings of non-human organ rejection, offering hope that organ shortages can be overcome through xenotransplantation. Over 100,000 patients are on organ transplant waiting […]